KEELER & NADLER FINANCIAL PLANNING & WEALTH MANAGEMENT

Position in ABBV — AbbVie Inc.

CIK 2035883 Dublin, OH

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$290,140

+$58,949 QoQ

Shares Held

1,153

+8.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#3,658

of 4,153 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KEELER & NADLER FINANCIAL PLANNING & WEALTH MANAGEMENT holds $839,151 across 3 Drug Manufacturers - General names. ABBV ranks #1 (34.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	1,153	$290,140
2	JNJ	Johnson & Johnson	1,127	$286,224
3	GILD	Gilead Sciences, Inc.	2,080	$262,787

All Filings in ABBV

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$290,140	1,153	+8.5%	Shares	Sole	2026-07-24
2026-03-31	$231,191	1,063	-9.1%	Shares	Sole	2026-05-04
2025-12-31	$267,104	1,169	0.0%	Shares	Sole	2026-01-27
2025-09-30	$270,670	1,169	+1.7%	Shares	Sole	2025-10-29
2025-06-30	$213,463	1,150	+0.3%	Shares	Sole	2025-07-28
2025-03-31	$240,319	1,147	+0.1%	Shares	Sole	2025-05-12
2024-12-31	$203,644	1,146	-0.1%	Shares	Sole	2025-01-14
2024-09-30	$226,509	1,147	+2.0%	Shares	Sole	2024-10-09
2024-03-31	$204,862	1,125	—	Shares	Sole	2024-10-03
No filing history on record for this holder in this stock.